Next 10 |
2024-04-19 17:10:14 ET More on ContraVir Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir Read the full article on Seeking Alpha For further details see: Hepion ends Phase ...
2024-04-19 14:48:33 ET More on Health Care Select Sector SPDR: XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among ...
2024-04-19 08:15:00 ET The healthcare industry can be a good place to invest for the long term. Demand for healthcare is only going to rise as the number of seniors goes up, and general population growth will also mean more of a need for devices, drugs, and healthcare services. Ev...
2024-04-18 12:40:00 ET Summary Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. Our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. Laughing Water Capital retu...
2024-04-17 12:02:34 ET More on Eli Lilly Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly obesity therapy succeeds in late-sta...
2024-04-17 07:04:07 ET More on Eli Lilly Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets GLP-1s ...
2024-04-17 03:10:00 ET Summary March CPI data was not what the bulls wanted to see, just as concerns about household spending emerge. This week, we profile a pair of domestic consumer companies, one from the Staples sector and one from Discretionary, with off-trend Q1 reporting da...
2024-04-16 14:16:55 ET Summary Just as the "Magnificent 7" stocks lead returns and headlines in US markets, an 11 stock basket called "GRANOLAS" have been called Europe's growth leaders. Here I run a head-to-head comparison using the Magnificent 7 as a proxy for the Invesco QQQ ET...
2024-04-16 12:38:35 ET More on Lexaria Bioscience Corp. Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes Lexaria slips despite FDA nod to test blood pressure drug Seeking Alpha’s Quant Rating on Lexaria Bioscience Corp. Historical ea...
2024-04-15 16:08:10 ET Summary Given the huge and growing GLP-1 weight loss market, recent trial data from Viking Therapeutics could make it a potential acquisition target for a larger concern. While many bigger pharma names might desire entry into the huge GLP-1 weight loss marke...
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
2024-04-19 08:15:00 ET The healthcare industry can be a good place to invest for the long term. Demand for healthcare is only going to rise as the number of seniors goes up, and general population growth will also mean more of a need for devices, drugs, and healthcare services. Ev...
Thursday, Germany’s competition authority, Bundeskartellamt, cleared the planned acquisition of Cardior Pharmaceuticals GmbH&n...
The GLP-1 class of drugs for weight loss has gained tremendous popularity but is struggling with a shortage that could extend into 2025. Who says t...